Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
AHK-Cu significantly stimulates vascular endothelial growth factor (VEGF), a key driver of angiogenesis, or the formation of new capillaries that deliver oxygen and nutrients to dermal tissue
GHK-Cu has a strong safety profile with no significant long-term risks identified
formal analyses of antibody formation or systemic immune responses after topical or parenteral administration are lacking
No safety data exists for these populations
The way a copper peptide is formulated and delivered may affect how well it reaches the intended tissue
Our multidisciplinary approach emphasizes personalized treatment plans, which may include medication management, physical therapy, behavioral health support, and lifestyle modifications
